By Brian Witte
January 13, 2020
EXCERPT:
A new board that will investigate how to keep prescription drugs affordable in Maryland met for the first time Monday to discuss hiring staff members and finding an office.
The five-member Maryland Prescription Drug Affordability Board will conduct studies on prescription drug costs. A study due later this year will focus on generic drug markets and how drug prices affect insurance premiums. The board also has a mandate to conduct an annual study on drug pricing trends.
“There’s a lot of studies,” said board chairman and former Maryland health secretary Van Mitchell.
One of the options available to the board is to recommend setting upper-payment limits to make high-cost drugs more affordable for state and local governments.
Last modified: January 14, 2020
